NEW YORK (GenomeWeb) – Grifols has garnered a CE-IVD mark for ID Core XT, a bead array-based assay for molecular blood group typing, the company said this week.
Spanish genetic testing firm Progenika Biopharma will continue to pursue its business objectives after Barcelona-based plasma products manufacturer Grifols acquired a 60 percent stake in the firm for for €37 million ($48.4 million), according to its CEO.
Norwegian molecular diagnostics firm Genetic Analysis announced two new developments last week. The first was the appointment of Kari Stenerson, a former Axis-Shield marketing director, as its new CEO.
NEW YORK (GenomeWeb News) – Progenika this week said that its CLIA laboratory has received accreditation from the College of American Pathologists.
The Medford, Mass.-based firm provides blood group genotyping services to blood banks and hospitals in the US and Canada.
CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.
In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.
